GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion
Giulia Grisendi(Semmelweis University), Massimo Dominici(University of Modena and Reggio Emilia), Stefano Luminari(University of Modena and Reggio Emilia), Satoru Otsuru(Children's Hospital of Philadelphia), Franco Bambi(Meyer Children's Hospital), Edwin M. Horwitz(St. Jude Children's Research Hospital), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Gian Luca Cervo(University of Modena and Reggio Emilia), Cecilia Annerén(Uppsala University), Paolo Paolucci(University of Modena and Reggio Emilia), Giovanni Palazzi(Azienda Ospedaliero-Universitaria di Modena), Michela Maur(Azienda Ospedaliero-Universitaria di Modena), Elena Veronesi(Semmelweis University), Luigi Cafarelli(Semmelweis University), Rita Sternieri(University of Modena and Reggio Emilia)
Cited by 70
Related Papers
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
|Blood|2010|265